These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 10600205)

  • 1. Physico-chemical analysis of Bordetella pertussis antigens.
    Bolgiano B; Crane DT; Xing D; Williams L; Jones C; Corbel MJ
    Biologicals; 1999 Jun; 27(2):155-62. PubMed ID: 10600205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Approaches to the control of acellular pertussis vaccines.
    Corbel MJ; Xing DK; Bolgiano B; Hockley DJ
    Biologicals; 1999 Jun; 27(2):133-41. PubMed ID: 10600202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid purification of pertussis toxin (PT) and filamentous hemagglutinin (FHA) by cation-exchange chromatography.
    Ozcengiz E; Kilinç K; Büyüktanir O; Günalp A
    Vaccine; 2004 Mar; 22(11-12):1570-5. PubMed ID: 15063583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of microcalorimetry to characterize tetanus neurotoxin, pertussis toxin and filamentous haemagglutinin.
    Krell T; Greco F; Nicolaï MC; Dubayle J; Renauld-Mongénie G; Poisson N; Bernard I
    Biotechnol Appl Biochem; 2003 Dec; 38(Pt 3):241-51. PubMed ID: 12911336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and preliminary characterization of agglutinogen 3 from Bordetella pertussis.
    Fredriksen JH; Frøholm LO; Paulsen BS
    Dev Biol Stand; 1985; 61():187-96. PubMed ID: 2872104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outer membrane vesicles as acellular vaccine against pertussis.
    Roberts R; Moreno G; Bottero D; Gaillard ME; Fingermann M; Graieb A; Rumbo M; Hozbor D
    Vaccine; 2008 Aug; 26(36):4639-46. PubMed ID: 18640169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine.
    Ausiello CM; Lande R; Urbani F; Di Carlo B; Stefanelli P; Salmaso S; Mastrantonio P; Cassone A
    J Infect Dis; 2000 Jun; 181(6):1989-95. PubMed ID: 10837180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Sero-Epidemiology Network 2: standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations.
    Giammanco A; Nardone A; Pebody R; Kafatos G; Andrews N; Chiarini A; Taormina S; de Ory F; Prosenc K; Krize B; Hallander H; Ljungman M; Marva E; Tsakris A; O'Flanagan D; Schneider F; Griskevicius A; Vranckx R; Karacs I
    Vaccine; 2008 Aug; 26(35):4486-93. PubMed ID: 18602434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous determination of Bordetella pertussis toxin and filamentous haemagglutinin concentrations by hydroxyapatite high-performance liquid chromatography.
    Chong P; Jackson G; Cwyk W; Klein M
    J Chromatogr; 1990 Jul; 512():227-36. PubMed ID: 2172264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tabtoxin-resistant protein: overexpression, purification, and characterization.
    Liu J; Le Y; Ye B; Zhen Y; Zhu C; Shen J; Zhang R
    Protein Expr Purif; 2002 Apr; 24(3):439-44. PubMed ID: 11922760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection.
    Alonso S; Pethe K; Mielcarek N; Raze D; Locht C
    Infect Immun; 2001 Oct; 69(10):6038-43. PubMed ID: 11553541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of the filamentous haemagglutinin of Bordetella pertussis studied with monoclonal antibodies.
    Irons LI; Ashworth LA; Wilton-Smith P
    J Gen Microbiol; 1983 Sep; 129(9):2769-78. PubMed ID: 6313862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective activity of the Bordetella pertussis BrkA autotransporter in the murine lung colonization model.
    Marr N; Oliver DC; Laurent V; Poolman J; Denoël P; Fernandez RC
    Vaccine; 2008 Aug; 26(34):4306-11. PubMed ID: 18582518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
    Prince HE; Lapé-Nixon M; Matud J
    Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physico-chemical characterization of growth hormone from water buffaloes (Bubalus bubalis).
    Maithal K; Krishnamurty HG; Muralidhar K
    Indian J Biochem Biophys; 2001 Dec; 38(6):375-83. PubMed ID: 11989667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rapid purification of Bordetella pertussis fimbria 2, 3 proteins and their immunogenicities].
    Atakan Ablay P; Ozcengiz E
    Mikrobiyol Bul; 2007 Jan; 41(1):11-20. PubMed ID: 17427548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fully liquid diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis--Haemophilus influenzae type b conjugate vaccine: immunogenicity and safety of primary vaccination in Taiwanese infants.
    Lin TY; Wang YH; Chang LY; Huang YC; Kao HT; Lin PY; Lu HK; Chavand P; Ortiz E
    Int J Infect Dis; 2007 Mar; 11(2):129-36. PubMed ID: 16762579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Verification of components of acellular pertussis vaccines that have been distributed solely, been in routine use for the last two decades and contributed greatly to control of pertussis in Japan.
    Kuno-Sakai H; Kimura M; Watanabe H
    Biologicals; 2004 Mar; 32(1):29-35. PubMed ID: 15026023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and partial characterization of filamentous haemagglutinin from Bordetella pertussis using monoclonal antibodies.
    Selmer JC; Larsen FS; Hertz JB; Parton R
    Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):279-84. PubMed ID: 6097092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cellular and acellular anti-pertussis vaccines].
    Locht C
    Ann Pharm Fr; 2001 May; 59(3):198-205. PubMed ID: 11427821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.